FDA Approved: LAPATINIB — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva's original application for a generic version of lapatinib for HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

ORIG AP for LAPATINIB (LAPATINIB)